drugset / Trial / NCT00567476
Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
This study investigated asthma-related quality of life in Brazilian patients using omalizumab.
Timeline
- Start
- 2007-11
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omalizumab | Monoclonal antibody | 150 mg | Subcutaneous |
| Comparator | Omalizumab | Monoclonal antibody | 375 mg | Subcutaneous |
| Comparator | Salbutamol | Unknown | 5 mg | Other |
| Comparator | Terbutaline | Small molecule | 10 mg | Other |